Close
Novotech
Jabsco PureFlo 21 Single Use

India Gives 2bn Doses of COVID With A 4-Month Rise In Cases

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Drug Manufacturing Deals Shift to Europe Despite Tariffs

Biopharma companies are continuing to redirect production strategies toward...

DeepCyte Raises $1.5M funding to Advance AI Drug Toxicology

DeepCyte, a techbio company focused on advancing AI Drug...

Hypercon Technology Deal Signed between Halozyme and Vertex

Halozyme Therapeutics has entered into a global exclusive partnership...
- Advertisement -

As daily infections reached a four-month high, the Indian government’s COVID-19 vaccinations touched 2 billion on July 17th. Booster doses are currently being administered to all people. Prime Minister Narendra Modi praised the vaccination milestone and celebrated the world’s largest and longest-running immunisation programme, which began last year.

India makes history once more!!, added PM Modi in a tweet. The opposition has accused the prime minister of mishandling the outbreak, which experts claim killed millions of people. The administration disputes the claims.

According to data from the health ministry, 49 deaths were reported overnight, bringing the COVID death toll to 525,709 in the country. The number of new cases increased by 20,528 during the last 24 hours, i.e. between July 16th and July 17th, reaching its highest level since February 20. The majority of COVID-related restrictions have been repealed in the 1.35 billion-strong nation, and global travel has made a strong comeback.

Covishield, a domestically produced vaccine by AstraZeneca, made up about 80% of the immunizations. Others include the Sputnik V from Russia and the locally made Covaxin and Corbevax.

In order to stop the spread of infections, the central government has stepped up its booster campaign, increasing its efforts in the eastern states of Assam and West Bengal, and Karnataka in the south.

Latest stories

Related stories

Drug Manufacturing Deals Shift to Europe Despite Tariffs

Biopharma companies are continuing to redirect production strategies toward...

DeepCyte Raises $1.5M funding to Advance AI Drug Toxicology

DeepCyte, a techbio company focused on advancing AI Drug...

Hypercon Technology Deal Signed between Halozyme and Vertex

Halozyme Therapeutics has entered into a global exclusive partnership...

Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal

Gilead Sciences has agreed to acquire Germany-based Tubulis in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »